메뉴 건너뛰기




Volumn 15, Issue 1, 2011, Pages 25-31

Challenges in pediatric transplantation: The impact of chronic kidney disease and cardiovascular risk factors on long-term outcomes and recommended management strategies

Author keywords

cardiovascular risk factors; chronic kidney disease; immunosuppression; kidney transplantation; long term outcomes; pediatric transplantation; tacrolimus

Indexed keywords

ALEMTUZUMAB; ALISKIREN; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDETATE CHROMIUM CR 51; FISH OIL; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEGA 3 FATTY ACID; PENTETATE TECHNETIUM TC 99M; RAPAMYCIN; TACROLIMUS;

EID: 78751658756     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01439.x     Document Type: Article
Times cited : (51)

References (39)
  • 1
    • 75149151496 scopus 로고    scopus 로고
    • Association of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: Data from the Italy - Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study
    • Sciarretta S, Valenti V, Tocci G, et al. Association of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: Data from the Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. J Hypertens 2010: 28: 251-258.
    • (2010) J Hypertens , vol.28 , pp. 251-258
    • Sciarretta, S.1    Valenti, V.2    Tocci, G.3
  • 2
    • 33749035484 scopus 로고    scopus 로고
    • Cardiovascular disease risk factors in chronic kidney disease: Overall burden and rates of treatment and control
    • Parikh NI, Hwang SJ, Larson MG, et al. Cardiovascular disease risk factors in chronic kidney disease: Overall burden and rates of treatment and control. Arch Intern Med 2006: 166: 1884-1891.
    • (2006) Arch Intern Med , vol.166 , pp. 1884-1891
    • Parikh, N.I.1    Hwang, S.J.2    Larson, M.G.3
  • 3
    • 0042632473 scopus 로고    scopus 로고
    • Cardiovascular calcifications in pediatric patients receiving maintenance dialysis
    • Sheth RD, Perez MD, Goldstein SL,. Cardiovascular calcifications in pediatric patients receiving maintenance dialysis. Pediatr Nephrol 2003: 18: 810-813.
    • (2003) Pediatr Nephrol , vol.18 , pp. 810-813
    • Sheth, R.D.1    Perez, M.D.2    Goldstein, S.L.3
  • 4
    • 0035571699 scopus 로고    scopus 로고
    • Undertreatment of cardiac risk factors in adolescents with renal failure
    • Querfeld U,. Undertreatment of cardiac risk factors in adolescents with renal failure. Perit Dial Int 2001: 21 (Suppl 3): S285-S291.
    • (2001) Perit Dial Int , vol.21 , Issue.SUPPL. 3
    • Querfeld, U.1
  • 5
    • 0034878053 scopus 로고    scopus 로고
    • Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients
    • Wang AYM, Woo J, Wang M, et al. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 2001: 12: 1927-1936.
    • (2001) J Am Soc Nephrol , vol.12 , pp. 1927-1936
    • Wang, A.Y.M.1    Woo, J.2    Wang, M.3
  • 6
    • 0035991583 scopus 로고    scopus 로고
    • Cardiovascular disease in pediatric chronic dialysis patients
    • Chavers BM, Li S, Collins AJ, Herzog CA,. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 2003: 62: 6480-6653.
    • (2003) Kidney Int , vol.62 , pp. 6480-6653
    • Chavers, B.M.1    Li, S.2    Collins, A.J.3    Herzog, C.A.4
  • 7
    • 0031738068 scopus 로고    scopus 로고
    • Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease
    • Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998: 32: 853-906.
    • (1998) Am J Kidney Dis , vol.32 , pp. 853-906
    • Levey, A.S.1    Beto, J.A.2    Coronado, B.E.3
  • 8
    • 2342648108 scopus 로고    scopus 로고
    • The clinical significance of vascular calcification in young patients with end-stage renal disease
    • Querfeld U,. The clinical significance of vascular calcification in young patients with end-stage renal disease. Pediatr Nephrol 2004: 19: 478-484.
    • (2004) Pediatr Nephrol , vol.19 , pp. 478-484
    • Querfeld, U.1
  • 9
    • 17844404295 scopus 로고    scopus 로고
    • Obesity and renal transplant outcome: A report of the North American Pediatric Renal Transplant Cooperative Study
    • Hanevold CD, Ho PL, Talley L, Mitsnefes MM,. Obesity and renal transplant outcome: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 2005: 115: 352-356.
    • (2005) Pediatrics , vol.115 , pp. 352-356
    • Hanevold, C.D.1    Ho, P.L.2    Talley, L.3    Mitsnefes, M.M.4
  • 10
    • 33746842369 scopus 로고    scopus 로고
    • Meta-analysis: Risk for hypertension in living kidney donors
    • Boudville N, Prasad GV, Knoll G, et al. Meta-analysis: Risk for hypertension in living kidney donors. Ann Intern Med 2006: 145: 185-196.
    • (2006) Ann Intern Med , vol.145 , pp. 185-196
    • Boudville, N.1    Prasad, G.V.2    Knoll, G.3
  • 11
    • 0036695863 scopus 로고    scopus 로고
    • Cardiovascular mortality in children and young adults with end-stage kidney disease
    • Parekh RS, Carroll CE, Wolfe RA, Port FK,. Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 2002: 141: 191-197.
    • (2002) J Pediatr , vol.141 , pp. 191-197
    • Parekh, R.S.1    Carroll, C.E.2    Wolfe, R.A.3    Port, F.K.4
  • 12
    • 4043052819 scopus 로고    scopus 로고
    • Risk factors for cardiovascular disease in pediatric renal transplant recipients
    • Silverstein DM,. Risk factors for cardiovascular disease in pediatric renal transplant recipients. Pediatr Transplant 2004: 8: 386-393.
    • (2004) Pediatr Transplant , vol.8 , pp. 386-393
    • Silverstein, D.M.1
  • 13
    • 0042360213 scopus 로고    scopus 로고
    • Chronic renal failure after transplantation of a nonrenal organ
    • Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003: 349: 931-940.
    • (2003) N Engl J Med , vol.349 , pp. 931-940
    • Ojo, A.O.1    Held, P.J.2    Port, F.K.3
  • 14
    • 37849035526 scopus 로고    scopus 로고
    • Complications of chronic kidney disease in children post-renal transplantation - A single center experience
    • Feber J, Wong H, Geier P, Chaudry B, Filler G,. Complications of chronic kidney disease in children post-renal transplantation-a single center experience. Pediatr Transplant 2008: 12: 80-84.
    • (2008) Pediatr Transplant , vol.12 , pp. 80-84
    • Feber, J.1    Wong, H.2    Geier, P.3    Chaudry, B.4    Filler, G.5
  • 15
    • 1342325543 scopus 로고    scopus 로고
    • The burden of chronic kidney disease in renal transplant recipients
    • Karthikeyan V, Karpinski J, Nair RC, Knoll G,. The burden of chronic kidney disease in renal transplant recipients. Am J Transplant 2004: 4: 262-269.
    • (2004) Am J Transplant , vol.4 , pp. 262-269
    • Karthikeyan, V.1    Karpinski, J.2    Nair, R.C.3    Knoll, G.4
  • 16
    • 70349647338 scopus 로고    scopus 로고
    • Monitoring kidney function and renal disease in children following transplant
    • Sharma AJ, Filler G,. Monitoring kidney function and renal disease in children following transplant. Ped Health 2009: 3: 155-163.
    • (2009) Ped Health , vol.3 , pp. 155-163
    • Sharma, A.J.1    Filler, G.2
  • 17
    • 33748445507 scopus 로고    scopus 로고
    • Chronic renal failure in non-renal organ transplant recipients
    • Nowicki M, Zwiech R,. Chronic renal failure in non-renal organ transplant recipients. Ann Transplant 2005: 10: 54-58.
    • (2005) Ann Transplant , vol.10 , pp. 54-58
    • Nowicki, M.1    Zwiech, R.2
  • 18
    • 36849005395 scopus 로고    scopus 로고
    • Chronic kidney disease after nonrenal solid-organ transplantation
    • Bloom RD, Reese PP,. Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol 2007: 18: 3031-3041.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 3031-3041
    • Bloom, R.D.1    Reese, P.P.2
  • 19
    • 35748970176 scopus 로고    scopus 로고
    • Tracking of blood pressure and its impact on graft function in pediatric renal transplant patients
    • Silverstein DM, Leblanc P, Hempe JM, Ramcharan T, Boudreaux JP,. Tracking of blood pressure and its impact on graft function in pediatric renal transplant patients. Pediatr Transplant 2007: 11: 860-867.
    • (2007) Pediatr Transplant , vol.11 , pp. 860-867
    • Silverstein, D.M.1    Leblanc, P.2    Hempe, J.M.3    Ramcharan, T.4    Boudreaux, J.P.5
  • 20
    • 17844406410 scopus 로고    scopus 로고
    • Blood pressure and graft outcome in renal transplantation
    • Berber I, Aydin C, Yigit B, et al. Blood pressure and graft outcome in renal transplantation. Transpl Proc 2005: 37: 997-998.
    • (2005) Transpl Proc , vol.37 , pp. 997-998
    • Berber, I.1    Aydin, C.2    Yigit, B.3
  • 21
    • 33644796696 scopus 로고    scopus 로고
    • Improved long-term outcomes after renal transplantation associated with blood pressure control
    • C ollaborative T ransplant S tudy
    • Opelz G, Döhler B,; C ollaborative T ransplant S tudy. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 2005: 5: 2725-2731.
    • (2005) Am J Transplant , vol.5 , pp. 2725-2731
    • Opelz, G.1    Döhler, B.2
  • 22
    • 0042243545 scopus 로고    scopus 로고
    • Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients
    • Mitsnefes MM, Khoury PR, Mcenery PT,. Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 2003: 143: 98-103.
    • (2003) J Pediatr , vol.143 , pp. 98-103
    • Mitsnefes, M.M.1    Khoury, P.R.2    McEnery, P.T.3
  • 23
    • 38649089470 scopus 로고    scopus 로고
    • Disease progression and the application of evidence-based treatment guidelines - Diagnose it early: A case for screening and appropriate management
    • Manley HJ,. Disease progression and the application of evidence-based treatment guidelines-Diagnose it early: A case for screening and appropriate management. J Manag Care Pharm 2007: 13: S6-S12.
    • (2007) J Manag Care Pharm , vol.13
    • Manley, H.J.1
  • 25
    • 0036329067 scopus 로고    scopus 로고
    • Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis
    • Dharnidharka VR, Kwon C, Stevens G,. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 2002: 40: 221-226.
    • (2002) Am J Kidney Dis , vol.40 , pp. 221-226
    • Dharnidharka, V.R.1    Kwon, C.2    Stevens, G.3
  • 26
    • 0141886061 scopus 로고    scopus 로고
    • Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula?
    • Filler G, Lepage N,. Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 2003: 18: 981-985.
    • (2003) Pediatr Nephrol , vol.18 , pp. 981-985
    • Filler, G.1    Lepage, N.2
  • 27
    • 33645903888 scopus 로고    scopus 로고
    • Estimating glomerular filtration rate in kidney transplantation: A comparison between serum creatinine and cystatin C-based methods
    • White C, Akbari A, Hussain N, et al. Estimating glomerular filtration rate in kidney transplantation: A comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol 2005: 16: 3763-3770.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 3763-3770
    • White, C.1    Akbari, A.2    Hussain, N.3
  • 28
    • 24144459534 scopus 로고    scopus 로고
    • Cardiovascular risk profile with the new immunosuppressive combinations after renal transplantation
    • Morales JM, Dominguez-Gil B,. Cardiovascular risk profile with the new immunosuppressive combinations after renal transplantation. J Hypertens 2005: 23: 1609-1616.
    • (2005) J Hypertens , vol.23 , pp. 1609-1616
    • Morales, J.M.1    Dominguez-Gil, B.2
  • 29
    • 33846103424 scopus 로고    scopus 로고
    • Preservation of renal function and cardiovascular risk factors
    • Van Hooff JP, Gelens M, Boots JM, et al. Preservation of renal function and cardiovascular risk factors. Transplant Proc 2006: 38: 1987-1991.
    • (2006) Transplant Proc , vol.38 , pp. 1987-1991
    • Van Hooff, J.P.1    Gelens, M.2    Boots, J.M.3
  • 30
    • 24644461627 scopus 로고    scopus 로고
    • Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy
    • Taylor AL, Watson CJ, Bradley JA,. Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol 2005: 56: 23-46.
    • (2005) Crit Rev Oncol Hematol , vol.56 , pp. 23-46
    • Taylor, A.L.1    Watson, C.J.2    Bradley, J.A.3
  • 31
    • 22844442933 scopus 로고    scopus 로고
    • Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure
    • Filler G, Womiloju T, Feber J, Lepage N, Christians U,. Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure. Am J Transplant 2005: 5: 2005-2010.
    • (2005) Am J Transplant , vol.5 , pp. 2005-2010
    • Filler, G.1    Womiloju, T.2    Feber, J.3    Lepage, N.4    Christians, U.5
  • 32
    • 49249112376 scopus 로고    scopus 로고
    • Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients
    • Celik S, Doesch A, Erbel C, et al. Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients. Transplantation 2008: 86: 245-250.
    • (2008) Transplantation , vol.86 , pp. 245-250
    • Celik, S.1    Doesch, A.2    Erbel, C.3
  • 33
    • 29144493230 scopus 로고    scopus 로고
    • Pharmacotherapy of hyperlipidemia in pediatric heart transplant recipients: Current practice and future directions
    • Chin C, Bernstein D,. Pharmacotherapy of hyperlipidemia in pediatric heart transplant recipients: Current practice and future directions. Paediatr Drugs 2005: 7: 391-396.
    • (2005) Paediatr Drugs , vol.7 , pp. 391-396
    • Chin, C.1    Bernstein, D.2
  • 34
    • 34247640280 scopus 로고    scopus 로고
    • Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: A meta-analysis
    • Jennings DL, Kalus JS, Coleman CI, Manierski C, Yee J,. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: A meta-analysis. Diabet Med 2007: 24: 486-493.
    • (2007) Diabet Med , vol.24 , pp. 486-493
    • Jennings, D.L.1    Kalus, J.S.2    Coleman, C.I.3    Manierski, C.4    Yee, J.5
  • 35
    • 0035816018 scopus 로고    scopus 로고
    • Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial
    • Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA 2001: 285: 2719-2728.
    • (2001) JAMA , vol.285 , pp. 2719-2728
    • Agodoa, L.Y.1    Appel, L.2    Bakris, G.L.3
  • 36
    • 34548594074 scopus 로고    scopus 로고
    • Risk factors for cardiovascular disease in children and young adults after renal transplantation
    • Becker-Cohen R, Nir A, Rinat C, et al. Risk factors for cardiovascular disease in children and young adults after renal transplantation. Clin J Am Soc Nephrol 2006: 1: 1284-1292.
    • (2006) Clin J Am Soc Nephrol , vol.1 , pp. 1284-1292
    • Becker-Cohen, R.1    Nir, A.2    Rinat, C.3
  • 37
    • 67449116317 scopus 로고    scopus 로고
    • Aliskiren: A novel renoprotective agent or simply an alternative to ACE inhibitors?
    • Wiggins KJ, Kelly DJ,. Aliskiren: A novel renoprotective agent or simply an alternative to ACE inhibitors? Kidney Int 2009: 76: 23-31.
    • (2009) Kidney Int , vol.76 , pp. 23-31
    • Wiggins, K.J.1    Kelly, D.J.2
  • 38
    • 23844485530 scopus 로고    scopus 로고
    • Four-year data after pediatric renal transplantation: A randomized trial of tacrolimus vs. cyclosporin microemulsion
    • Filler G, Webb NJ, Milford DV, et al. Four-year data after pediatric renal transplantation: A randomized trial of tacrolimus vs. cyclosporin microemulsion. Pediatr Transplant 2005: 9: 498-503.
    • (2005) Pediatr Transplant , vol.9 , pp. 498-503
    • Filler, G.1    Webb, N.J.2    Milford, D.V.3
  • 39
    • 55949095133 scopus 로고    scopus 로고
    • Patient selection critical for calcineurin inhibitor withdrawal in pediatric kidney transplantation
    • Weintraub L, Li L, Kambham N, et al. Patient selection critical for calcineurin inhibitor withdrawal in pediatric kidney transplantation. Pediatr Transplant 2008: 12: 541-549.
    • (2008) Pediatr Transplant , vol.12 , pp. 541-549
    • Weintraub, L.1    Li, L.2    Kambham, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.